GU Research Network, LLC / Urology Cancer Center — Omaha, Nebraska

GU Research Network, LLC / Urology Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

GU Research Network, LLC / Urology Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GU Research Network, LLC / Urology Cancer Center?

GU Research Network, LLC / Urology Cancer Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GU Research Network, LLC / Urology Cancer Center conducted?

GU Research Network, LLC / Urology Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate.

Is GU Research Network, LLC / Urology Cancer Center accredited by Crixeo Health?

GU Research Network, LLC / Urology Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GU Research Network, LLC / Urology Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.